US based Woolsey Pharmaceuticals has announced that it has completed a license agreement with Japanese pharmaceutical co...
Eisai Inc., the U.S. subsidiary of Eisai Co., Ltd., has announced the launch of Ella the Jellyfish, the first Amaz...
Japan based Shionogi & Co., Ltd. has announced the U.S. Food and Drug Administration (FDA) has approved FETROJA®...
Tokyo headquartered Eisai Co., Ltd. announced that it has launched the Equfina® 50mg TABLETS (safinamide mesila...
Japan headquartered Astellas Pharma Inc. and US based Welldoc, Inc. have entered into a collaboration and license agreem...
Merck, a leading science and technology company, has announced that the Japanese Ministry of Health, Labour and Welfare ...
Japan headquartered Toray Industries, Inc., has made an agreement with the Japan International Cooperation Agency (JICA)...
Sandoz has announced that it has entered into a binding agreement for the planned acquisition of the Japanese business o...
Indian pharma major Lupin Limited (including its subsidiaries, together referred to as ‘Lupin’) a...
Cancer Intelligence Care Systems, Inc. (CICS) and STELLA PHARMA CORPORATION will commence a Phase I clinical trial of Bo...
Japan headquartered Takeda Pharmaceutical Company Limited recentky hosted an R&D meeting in New York City to ou...
Japan based NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focu...
Japan headquartered Yokogawa Electric Corporation announces that it has acquired a nanopipette technology that was devel...
Novo Nordisk A/S and Japanese chemical company UBE Industries Ltd. recently announced that Novo Nordisk has obtained an ...
University of Texas MD Anderson Cancer Center (The University of Texas MD Anderson Cancer Center) and Takeda P...
Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) solutions for clinical trials, has announce...
Fujitsu, on 7 Nov 2019, announced the results of a joint research project it has been conducting with the Institute of M...
Japan based Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of ...
